Want to join the conversation?
$CHK posted a narrower loss in 2Q16, helped by lower OpEx compared to 2Q15. Net loss available to common stockholders was $1.79Bil or $2.48 per share compared to net loss of $4.15Bil or $6.27 per share last year. Revenues declined by 54% YoverY to $1.62Bil. Adjusted net loss available to common stockholders was $145MM or $0.14 per common share.
$YHOO is reporting today after market close. Nobody cares about this stock.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.